In adenocarcinomas of the lung, Fan and colleagues found a significant correlation between the expression of the purinergic receptor P2Y12 (P2RY12) and the degree of tumor infiltration with immunosuppressive TAMs [56]. This evidence concerns the gene P2RY12 and neoplasm.